107 related articles for article (PubMed ID: 16632807)
21. Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction.
Stumpner J; Redel A; Kellermann A; Lotz CA; Blomeyer CA; Smul TM; Kehl F; Roewer N; Lange M
Anesthesiology; 2009 Dec; 111(6):1257-64. PubMed ID: 19934869
[TBL] [Abstract][Full Text] [Related]
22. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
Gao HK; Yin Z; Zhou N; Feng XY; Gao F; Wang HC
J Cardiovasc Pharmacol; 2008 Sep; 52(3):286-92. PubMed ID: 18806610
[TBL] [Abstract][Full Text] [Related]
23. The protective effects of emulsified isoflurane on myocardial ischemia and reperfusion injury in rats.
Hu ZY; Luo NF; Liu J
Can J Anaesth; 2009 Feb; 56(2):115-25. PubMed ID: 19247759
[TBL] [Abstract][Full Text] [Related]
24. Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats.
Wang C; Weihrauch D; Schwabe DA; Bienengraeber M; Warltier DC; Kersten JR; Pratt PF; Pagel PS
Anesth Analg; 2006 Aug; 103(2):281-8, table of contents. PubMed ID: 16861403
[TBL] [Abstract][Full Text] [Related]
25. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta.
Park SS; Zhao H; Mueller RA; Xu Z
J Mol Cell Cardiol; 2006 May; 40(5):708-16. PubMed ID: 16516918
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
[TBL] [Abstract][Full Text] [Related]
27. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion.
Kobayashi H; Miura T; Ishida H; Miki T; Tanno M; Yano T; Sato T; Hotta H; Shimamoto K
Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):812-9. PubMed ID: 18346168
[TBL] [Abstract][Full Text] [Related]
28. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts.
Chen HT; Yang CX; Li H; Zhang CJ; Wen XJ; Zhou J; Fan YL; Huang T; Zeng YM
Acta Pharmacol Sin; 2008 Aug; 29(8):931-41. PubMed ID: 18664326
[TBL] [Abstract][Full Text] [Related]
29. Desflurane-induced and ischaemic postconditioning against myocardial infarction are mediated by Pim-1 kinase.
Stumpner J; Smul TM; Redel A; Hilz T; Tischer-Zeitz T; Eisenbarth H; Schick MA; Kehl F; Roewer N; Lange M
Acta Anaesthesiol Scand; 2012 Aug; 56(7):904-13. PubMed ID: 22385356
[TBL] [Abstract][Full Text] [Related]
30. Isoflurane inhaled at the onset of reperfusion potentiates the cardioprotective effect of ischemic postconditioning through a NO-dependent mechanism.
Tessier-Vetzel D; Tissier R; Waintraub X; Ghaleh B; Berdeaux A
J Cardiovasc Pharmacol; 2006 Mar; 47(3):487-92. PubMed ID: 16633094
[TBL] [Abstract][Full Text] [Related]
31. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
[TBL] [Abstract][Full Text] [Related]
32. Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: role of HIF1 alpha and CREB.
Feng J; Lucchinetti E; Fischer G; Zhu M; Zaugg K; Schaub MC; Zaugg M
Cardiovasc Res; 2008 Apr; 78(1):98-107. PubMed ID: 18218685
[TBL] [Abstract][Full Text] [Related]
33. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
34. Desflurane-induced cardioprotection against ischemia-reperfusion injury depends on timing.
Smul TM; Lange M; Redel A; Stumpner J; Lotz CA; Roewer N; Kehl F
J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):600-6. PubMed ID: 19167913
[TBL] [Abstract][Full Text] [Related]
35. Postconditioning prevents reperfusion injury by activating delta-opioid receptors.
Jang Y; Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
Anesthesiology; 2008 Feb; 108(2):243-50. PubMed ID: 18212569
[TBL] [Abstract][Full Text] [Related]
36. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
[TBL] [Abstract][Full Text] [Related]
37. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological postconditioning with the phytoestrogen genistein.
Tissier R; Waintraub X; Couvreur N; Gervais M; Bruneval P; Mandet C; Zini R; Enriquez B; Berdeaux A; Ghaleh B
J Mol Cell Cardiol; 2007 Jan; 42(1):79-87. PubMed ID: 17141266
[TBL] [Abstract][Full Text] [Related]
39. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
[TBL] [Abstract][Full Text] [Related]
40. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis.
Cohen MV; Yang XM; Downey JM
Circulation; 2007 Apr; 115(14):1895-903. PubMed ID: 17389262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
